Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 13Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 18Melanoma 13Neoplasms 5Head and Neck Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Lung Neoplasms 4Stomach Neoplasms 3Neoplasm Metastasis 2Kidney Neoplasms 2Gastrointestinal Neoplasms 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Hepatocellular 2Thyroid Neoplasms 1Skin Neoplasms 1Sexual Dysfunction, Physiological 1Sarcopenia 1Recurrent Squamous Cell Lung Carcinoma 1Recurrence 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Oropharyngeal Neoplasms 1Neoplasms, Squamous Cell 1Motor Activity 1Lung Squamous Cell Carcinoma Stage IV 1Locally Advanced Melanoma 1Locally Advanced Gastric Cancer 1Liver Diseases 1Hereditary Sensory and Autonomic Neuropathies 1Eunuchism 1Esophageal Neoplasms 1Erectile Dysfunction 1

Interventions

Liquid Biopsy 4Blood Specimen Collection 4Gemcitabine 3pembrolizumab 2Immunohistochemistry 2Cisplatin 2Capecitabine 2Base Sequence 2130-nm albumin-bound paclitaxel 2tislelizumab 1taxane 1lenvatinib 1irinotecan sucrosofate 1gemcitabine-oxaliplatin regimen 1Tegafur 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1S 1 (combination) 1Polymerase Chain Reaction 1Platinum Compounds 1Oxaliplatin 1Nivolumab 1Microscopy, Confocal 1Methylation 1Mass Spectrometry 1Leucovorin 1Irinotecan 1Immune Checkpoint Inhibitors 1High-Throughput Nucleotide Sequencing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Biliary Tract Neoplasms × Nivolumab × Clear all
NCT03695952 2025-01-28

A Prospective Cohort Study of Patients with Hepatobiliary Cancer Treated with Immune Checkpoint Inhibitors

Asan Medical Center

Active not recruiting
100 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡